| Literature DB >> 34312136 |
Gabriel Torrealba-Acosta1, Jennifer C Martin2, Yve Huttenbach3, Catherine R Garcia4, Muhammad R Sohail5, Sandeep Krishna Agarwal6, Carina Wasko2, Eric M Bershad4, Mohammad I Hirzallah4.
Abstract
A patient presented with fever, generalised rash, confusion, orofacial movements and myoclonus after receiving the first dose of mRNA-1273 vaccine from Moderna. MRI was unremarkable while cerebrospinal fluid showed leucocytosis with lymphocyte predominance and hyperproteinorrachia. The skin evidenced red, non-scaly, oedematous papules coalescing into plaques with scattered non-follicular pustules. Skin biopsy was consistent with a neutrophilic dermatosis. The patient fulfilled the criteria for Sweet syndrome. A thorough evaluation ruled out alternative infectious, autoimmune or malignant aetiologies, and all manifestations resolved with glucocorticoids. While we cannot prove causality, there was a temporal correlation between the vaccination and the clinical findings. © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: COVID-19; dermatology; neurology; unwanted effects / adverse reactions; vaccination/immunisation
Year: 2021 PMID: 34312136 DOI: 10.1136/bcr-2021-243173
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X